Precision medicine meets public health: population screening for BRCA1 and BRCA2

J Natl Cancer Inst. 2014 Dec 30;107(1):420. doi: 10.1093/jnci/dju420. Print 2015 Jan.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • BRCA1 Protein / genetics*
  • BRCA2 Protein / genetics*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / prevention & control*
  • Early Detection of Cancer*
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Heterozygote
  • Humans
  • Jews / genetics
  • Mass Screening* / methods
  • Mutation*
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / prevention & control*
  • Population Surveillance*
  • Public Health* / trends
  • Risk Assessment

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human